Physician profile
Kyle Liban
NPI 1912301466
$2,738.37
in general payments reported to CMS, 2019-2025
14 companies · $471 in 2025
The $471 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $421 · 2022: $360 · 2023: $924 · 2024: $562 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,956.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $543.53 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $444.89 | 2023-2024 | Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $365.02 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $319.85 | 2023-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $267.27 | 2021-2024 | |
| Bridgebio Pharma, INC. | $232.62 | 2025 | Attruby |
| Pfizer INC. | $186.31 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $124.10 | 2022-2024 | Eliquis, Camzyos |
| Amgen INC. | $79.74 | 2022-2025 | Repatha, Repatha |
| Kestra Medical Technology Services, INC. | $48.55 | 2025 | Assure Wcd |
| Scpharmaceuticals INC. | $43.65 | 2024 | |
| Abiomed | $37.49 | 2025 | |
| Nuwellis, INC. | $29.05 | 2024 | Aquadex Smartflow Console |
| Bayer Healthcare Pharmaceuticals INC. | $16.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Liban listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.